Fetal Lung Maturity Testing: The End of an Era

References

• Kaplan F . Molecular determinants of fetal lung organogenesis.Mol. Genet. Metab.71 ( 1–2 ), 321 – 341 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Mcmurtry IF . Introduction: pre- and postnatal lung development, maturation, and plasticity.Am. J. Physiol. Lung Cell. Mol. Physiol.282 ( 3 ), L341 – 344 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Whitsett JA . Composition of pulmonary surfactant lipids and proteins . In: Fetal and Neonatal Physiology . PolinRA (Ed.). Saunders , PA, USA , 1005 – 1013 ( 2004 ).
   Google Scholar
• Moore TR . A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy.Am. J. Obstet. Gynecol.186 ( 4 ), 641 – 650 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ashwood E . Markers of fetal lung maturity . In: Handbook of Clinical Laboratory Testing During Pregnancy .  GronowskiA  (Ed.).  Humana Press ,  NY, USA , 55 – 70 ( 2004 ).
   Google Scholar
• Verma RP . Respiratory distress syndrome of the newborn infant.Obstet. Gynecol. Surv.50 ( 7 ), 542 – 555 ( 1995 ).
   PubMedGoogle Scholar
• Dubin SB . Assessment of fetal lung maturity: in search of the Holy Grail.Clin. Chem.36 ( 11 ), 1867 – 1869 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Murphy SL XJ , KochanekKD . Deaths: final Data for 2010.Natl Vital Stat. Rep.61 ( (4 ) ) 1 – 118 ( (2013 ). ).  
   PubMedGoogle Scholar
• Grenache DG , GronowskiAM . Fetal lung maturity.Clin. Biochem.39 ( 1 ), 1 – 10 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Leung-Pineda V , GronowskiAM . Biomarker tests for fetal lung maturity.Biomark. Med.4 ( 6 ), 849 – 857 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Gluck L , KulovichMV , BorerRCJr , BrennerPH , AndersonGG , SpellacyWN . Diagnosis of the respiratory distress syndrome by amniocentesis.Am. J. Obstet. Gynecol.109 ( 3 ), 440 – 445 ( 1971 ).
   PubMed Web of Science ®Google Scholar
• Gluck L , KulovichMV . Lecithin-sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy.Am. J. Obstet. Gynecol.115 ( 4 ), 539 – 546 ( 1973 ).
   PubMed Web of Science ®Google Scholar
• Kulovich MV , HallmanMB , GluckL . The lung profile. I. Normal pregnancy.Am. J. Obstet. Gynecol.135 ( 1 ), 57 – 63 ( 1979 ).
   PubMed Web of Science ®Google Scholar
• Garite TJ , YabusakiKK , MobergLJet al. A new rapid slide agglutination test for amniotic fluid phosphatidylglycerol. laboratory and clinical correlation. Am. J. Obstet. Gynecol. 147 ( 6 ), 681 – 686 ( 1983 ).
   PubMed Web of Science ®Google Scholar
• Hook GE , GilmoreLB , TombropoulosEG , FabroSE . Fetal lung lamellar bodies in human amniotic fluid.Am. Rev. Respir. Dis.117 ( 3 ), 541 – 550 ( 1978 ).
   PubMedGoogle Scholar
• Morris MW , DaveyFR . Basic examination of blood . In: Clinical Diagnosis and Management by Laboratory Methods . HenryJB (Ed.). Saunders , PA, USA , 479 – 519 ( 2001 ).
   Google Scholar
• Shinitzky M , GoldfisherA , BruckAet al. A new method for assessment of fetal lung maturity. Br. J. Obstet. Gynecol. 83 ( 11 ), 838 – 844 ( 1976 ).
   PubMedGoogle Scholar
• Besnard AE , WirjosoekartoSA , BroezeKA , OpmeerBC , MolBW . Lecithin/sphingomyelin ratio and lamellar body count for fetal lung maturity: a meta-analysis.Eur. J. Obstet. Gynecol. Reprod. Biol.169 ( 2 ), 177 – 183 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhao Q , ZhaoZ , Leung-PinedaVet al. Predicting respiratory distress syndrome using gestational age and lamellar body count. Clin. Biochem. 46 ( 13–14 ), 1228 – 1232 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Grenache DG , WilsonAR , GrossGA , GronowskiAM . Clinical and laboratory trends in fetal lung maturity testing.Clin. Chim. Acta411 ( 21–22 ), 1746 – 1749 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mcginnis KT , BrownJA , MorrisonJC . Changing patterns of fetal lung maturity testing.J. Perinatol.28 ( 1 ), 20 – 23 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Gottwein E , CullenBR . Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.Cell Host Microbe3 ( 6 ), 375 – 387 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hou J , WangP , LinLet al. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183 ( 3 ), 2150 – 2158 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Martin JA , HamiltonBE , SuttonPDet al. Births: final data for 2006. Natl Vital Stat. Rep. 57 ( 7 ), 1 – 102 , ( 2009 ).
   Google Scholar
• Osterman MJ , MartinJA . Changes in cesarean delivery rates by gestational age: United States, 1996–2011.NCHS Data Brief ( 124 ), 1 – 8 . ( 2013 ).
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists . ACOG committee opinion No. 561. Nonmedically indicated early-term deliveries.Obstet Gynecol.121 ( 4 ), 911 – 915 ( 2013 ).
   PubMedGoogle Scholar
• Tita AT , LandonMB , SpongCYet al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N. Engl. J. Med. 360 ( 2 ), 111 – 120 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Reddy UM , KoCW , RajuTN , WillingerM . Delivery indications at late-preterm gestations and infant mortality rates in the United States.Pediatrics124 ( 1 ), 234 – 240 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bates E , RouseDJ , MannML , ChapmanV , CarloWA , TitaAT . Neonatal outcomes after demonstrated fetal lung maturity before 39 weeks of gestation.Obstet. Gynecol.116 ( 6 ), 1288 – 1295 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kamath BD , MarcotteMP , DefrancoEA . Neonatal morbidity after documented fetal lung maturity in late preterm and early term infants.Am. J. Obstet. Gynecol.204 ( 6 ), 518 e511–e518 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Fang YM , GuirguisP , BorgidaA , FeldmanD , IngardiaC , HersonV . Increased neonatal morbidity despite pulmonary maturity for deliveries occurring before 39 weeks.J. Matern. Fetal Neonatal Med.26 ( 1 ), 79 – 82 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ballard PL , BallardRA . Scientific basis and therapeutic regimens for use of antenatal glucocorticoids.Am. J. Obstet. Gynecol.173 ( 1 ), 254 – 262 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Crowley P . Prophylactic corticosteroids for preterm birth.Cochrane Database Syst. Rev.2 , CD000065 , ( 2000 ).
   Google Scholar
• Roberts D , DalzielS . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane Database Syst. Rev.3 , CD004454 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Suresh GK , SollRF . Overview of surfactant replacement trials.J. Perinatol.25 ( Suppl. 2 ), S40 – S44 ( 2005 ).
   PubMedGoogle Scholar
• Bahadue FL , SollR . Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.Cochrane Database Syst. Rev.11 , CD001456 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rojas-Reyes MX , MorleyCJ , SollR . Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.Cochrane Database Syst. Rev.3 , CD000510 ( 2012 ).
   Google Scholar
• Finer NN , CarloWA , WalshMCet al. Early CPAP versus surfactant in extremely preterm infants. N. Engl. J. Med. 362 ( 21 ), 1970 – 1979 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sandri F , PlavkaR , AncoraGet al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 125 ( 6 ), e1402 – 1409 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Halliday HL . Surfactants: past, present and future.J. Perinatol.28 ( Suppl. 1 ), S47 – S56 ( 2008 ).
   PubMedGoogle Scholar
• Spong CY . Defining ‘term’ pregnancy: recommendations from the Defining ‘Term’ Pregnancy Workgroup.JAMA309 ( 23 ), 2445 – 2446 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists . ACOG committee opinion no. 560. Medically indicated late-preterm and early-term deliveries.Obstet Gynecol.121 ( 4 ), 908 – 910 ( 2013 ).
   PubMedGoogle Scholar